BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 9102180)

  • 1. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.
    Labeur C; Lins L; Vanloo B; Baert J; Brasseur R; Rosseneu M
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):580-8. PubMed ID: 9102180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides.
    Yancey PG; Bielicki JK; Johnson WJ; Lund-Katz S; Palgunachari MN; Anantharamaiah GM; Segrest JP; Phillips MC; Rothblat GH
    Biochemistry; 1995 Jun; 34(24):7955-65. PubMed ID: 7794908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein.
    Davidson WS; Lund-Katz S; Johnson WJ; Anantharamaiah GM; Palgunachari MN; Segrest JP; Rothblat GH; Phillips MC
    J Biol Chem; 1994 Sep; 269(37):22975-82. PubMed ID: 8083197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of end group blockage on the properties of a class A amphipathic helical peptide.
    Venkatachalapathi YV; Phillips MC; Epand RM; Epand RF; Tytler EM; Segrest JP; Anantharamaiah GM
    Proteins; 1993 Apr; 15(4):349-59. PubMed ID: 8460106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic model peptides for apolipoproteins. II. Characterization of the discoidal complexes generated between phospholipids and synthetic model peptides for apolipoproteins.
    Corijn J; Deleys R; Labeur C; Vanloo B; Lins L; Brasseur R; Baert J; Ruysschaert JM; Rosseneu M
    Biochim Biophys Acta; 1993 Sep; 1170(1):8-16. PubMed ID: 8399330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lecithin:cholesterol acyltransferase activation by synthetic amphipathic peptides.
    Subbarao NK; Fielding CJ; Hamilton RL; Szoka FC
    Proteins; 1988; 3(3):187-98. PubMed ID: 3255105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the hydrophobicity gradient of an amphipathic peptide to its mode of association with lipids.
    Pérez-Méndez O; Vanloo B; Decout A; Goethals M; Peelman F; Vandekerckhove J; Brasseur R; Rosseneu M
    Eur J Biochem; 1998 Sep; 256(3):570-9. PubMed ID: 9780233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of synthetic peptide analogs of the amphipathic helix. Effect of charge distribution, hydrophobicity, and secondary structure on lipid association and lecithin:cholesterol acyltransferase activation.
    Epand RM; Gawish A; Iqbal M; Gupta KB; Chen CH; Segrest JP; Anantharamaiah GM
    J Biol Chem; 1987 Jul; 262(19):9389-96. PubMed ID: 3597415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.
    Mendez AJ; Anantharamaiah GM; Segrest JP; Oram JF
    J Clin Invest; 1994 Oct; 94(4):1698-705. PubMed ID: 7929849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.
    Datta G; Chaddha M; Hama S; Navab M; Fogelman AM; Garber DW; Mishra VK; Epand RM; Epand RF; Lund-Katz S; Phillips MC; Segrest JP; Anantharamaiah GM
    J Lipid Res; 2001 Jul; 42(7):1096-104. PubMed ID: 11441137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein A-I: structure-function relationships.
    Frank PG; Marcel YL
    J Lipid Res; 2000 Jun; 41(6):853-72. PubMed ID: 10828078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of lipid complexes with amphipathic helix-forming peptides. Role of distribution of peptide charges.
    Epand RM; Surewicz WK; Hughes DW; Mantsch H; Segrest JP; Allen TM; Anantharamaiah GM
    J Biol Chem; 1989 Mar; 264(8):4628-35. PubMed ID: 2925658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recruitment of cell phospholipids and cholesterol by apolipoproteins A-II and A-I: formation of nascent apolipoprotein-specific HDL that differ in size, phospholipid composition, and reactivity with LCAT.
    Forte TM; Bielicki JK; Goth-Goldstein R; Selmek J; McCall MR
    J Lipid Res; 1995 Jan; 36(1):148-57. PubMed ID: 7706940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins.
    Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL
    Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of synthetic peptide analogs of the amphipathic helix. Correlation of structure with function.
    Chung BH; Anatharamaiah GM; Brouillette CG; Nishida T; Segrest JP
    J Biol Chem; 1985 Aug; 260(18):10256-62. PubMed ID: 4019511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic model peptides for apolipoproteins. I. Design and properties of synthetic model peptides for the amphipathic helices of the plasma apolipoproteins.
    Brasseur R; Vanloo B; Deleys R; Lins L; Labeur C; Taveirne J; Ruysschaert JM; Rosseneu M
    Biochim Biophys Acta; 1993 Sep; 1170(1):1-7. PubMed ID: 8399322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional properties of the 154-171 wild-type and variant peptides of human lecithin-cholesterol acyltransferase.
    Peelman F; Goethals M; Vanloo B; Labeur C; Brasseur R; Vandekerckhove J; Rosseneu M
    Eur J Biochem; 1997 Nov; 249(3):708-15. PubMed ID: 9395317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of synthetic peptide analogues to localize lecithin:cholesterol acyltransferase activating domain in apolipoprotein A-I.
    Anantharamaiah GM; Venkatachalapathi YV; Brouillette CG; Segrest JP
    Arteriosclerosis; 1990; 10(1):95-105. PubMed ID: 2105091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention of α-helical structure by HDL mimetic peptide ATI-5261 upon extensive dilution represents an important determinant for stimulating ABCA1 cholesterol efflux with high efficiency.
    Zheng Y; Patel AB; Narayanaswami V; Bielicki JK
    Biochem Biophys Res Commun; 2013 Nov; 441(1):71-6. PubMed ID: 24129191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
    Sparks DL; Frank PG; Neville TA
    Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.